The efficacy of combination therapy using adeno-associated virus-mediated co-expression of apoptin and interleukin-24 on hepatocellular carcinoma
- 2 August 2013
- journal article
- research article
- Published by Springer Nature in Tumor Biology
- Vol. 34 (5) , 3027-3034
Abstract
Multigene-based combination therapy is an effective practice in cancer gene therapy. Apoptin is a chicken anemia virus-derived, p53-independent, Bcl-2-insensitive apoptotic protein with the ability to specifically induce apoptosis in various human tumor cells. Interleukin-24 (IL-24) displays ubiquitous antitumor property and tumor-specific killing activity. Adeno-associated virus (AAV) is a promising gene delivery vehicle due to its advantage of low pathogenicity and long-term gene expression. In this study, we assessed the efficacy of combination therapy using AAV-mediated co-expression of apoptin and interleukin-24 on hepatocellular carcinoma in vitro and in vivo. Our results showed that AAV-mediated co-expression of IL-24 and apoptin significantly suppressed the growth and induced the apoptosis of HepG2 cells in vitro. Furthermore, AAV-mediated combined treatment of IL-24 and apoptin significantly suppressed tumor growth and induced apoptosis of tumor cells in xenograft nude mice. These data suggest that AAV vectors that co-express apoptin and IL-24 have great potential in cancer gene therapy.Keywords
This publication has 17 references indexed in Scilit:
- Apoptin selectively induces the apoptosis of tumor cells by suppressing the transcription of HSP70Tumor Biology, 2012
- ADAM10 overexpression confers resistance to doxorubicin-induced apoptosis in hepatocellular carcinomaTumor Biology, 2012
- Combinatorial Effect of Non-Steroidal Anti-inflammatory Drugs and NF-κB Inhibitors in Ovarian Cancer TherapyPLOS ONE, 2011
- Enhanced tumor suppression by an ING4/IL-24 bicistronic adenovirus-mediated gene cotransfer in human non-small cell lung cancer cellsCancer Gene Therapy, 2011
- Apoptin, a tumor-selective killerBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2009
- Molecular targeted therapies in hepatocellular carcinoma: From pre-clinical models to clinical trialsJournal of Hepatology, 2008
- Caspase-, cathepsin-, and PERK-dependent regulation of MDA-7/IL-24-induced cell killing in primary human glioma cellsMolecular Cancer Therapeutics, 2008
- Global Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2005
- Conversion of Bcl-2 from Protector to Killer by Interaction with Nuclear Orphan Receptor Nur77/TR3Cell, 2004
- The Hallmarks of CancerCell, 2000